An 8-week Follow-up to Evaluate the Renewal of Corneal Nerves Structure and Function in Patients With Neurotrophic Keratopathy Treated With Recombinant Human Nerve Growth Factor (rhNGF) Eyedrops

NCT04293549 · clinicaltrials.gov ↗

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Neurotrophic Keratopathy

Interventions

DRUG: Cenegermin, recombinant human Nerve Growth Factor (rhNGF) eyedrops

Sponsor

G. d'Annunzio University